Christopher Mennone Joins Surefire Medical Team As International Business Director
WESTMINSTER, Colo., Sept. 13, 2012 /PRNewswire/ — Surefire Medical, Inc., a Colorado-based medical device company, announced today that Christopher Mennone has joined the management team as Director of International Business.
“We’re eager to have Chris join our team and begin to make an immediate impact in establishing our international presence,” said Jim Chomas, CEO of Surefire Medical. “Chris has more than 30 years of experience building strategic relationships with hundreds of physicians, business partners and international distributors throughout the world, which is critical to our long-term success in the marketplace.”
Prior to joining the Surefire team, Mennone created sales and marketing organizations using the direct sales model in as many as 17 markets and the distributor channel in more than 80 markets. Mennone held the position of Director of International Sales for Medivance, Inc., a medical device manufacturer that was recently acquired by CR Bard, Inc. (BCR). During his career Mennone also ran the international business areas for Intermedics Intraocular (Pasadena, Calif.), Arrow International (Reading, Pa.) and Artromick International (Columbus, Ohio).
Mennone earned his Master’s of International Management degree from the Thunderbird School of Global Management in Glendale, Ariz. and a Bachelor’s of Arts degree from Hofstra University in Hempstead, N.Y.
About Surefire Medical
Surefire Medical, Inc., based in Westminster, Colo., was founded in 2009 to develop an innovative infusion system for the interventional radiology and interventional oncology markets. The Company’s initial product, the Surefire® Infusion System, is designed to precisely deliver embolic agents through the sophisticated expandable tip portion of its catheter. The Surefire expandable tip is designed to collapse in forward flow and dynamically expand to the vessel wall in reverse flow, in order to increase embolization efficiency, minimize reflux and reduce damage to healthy tissue. The Surefire Infusion System has received 510(k) clearance from the U.S. FDA and the European CE Mark. Surefire’s newest product, the Surefire High-Flow Microcatheter, has also received FDA 510(k) clearance. For more information, please visit www.surefiremedical.com.
SOURCE Surefire Medical, Inc.